Literature DB >> 1703350

Beneficial effect of recombinant human glycosylated granulocyte colony-stimulating factor in marrow-transplanted patients: results of multicenter phase II-III studies.

S Asano1, T Masaoka, F Takaku.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1703350

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 2.  Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.

Authors:  J E Frampton; Y E Yarker; K L Goa
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

3.  Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.

Authors:  M J Laughlin; G Kirkpatrick; N Sabiston; W Peters; J Kurtzberg
Journal:  Ann Hematol       Date:  1993-12       Impact factor: 3.673

Review 4.  Cytokines and bone marrow transplantation.

Authors:  F Takaku
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.